Osteosarcoma exocytosis of soluble LGALS3BP mediates macrophages toward a tumoricidal phenotype

Jing Li1, Chenguang Zhao2, Yuhuan Li1

  • 1Department of Orthopedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, PR China.

Cancer Letters
|December 24, 2021
PubMed

Insights

Osteosarcoma (OS) growth is inhibited by M1 macrophages secreting HSPA1L, impacting tumor cell apoptosis via IRAK pathways. Targeting tumor-associated macrophages (TAMs) offers a novel therapeutic strategy for osteosarcoma.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Osteosarcoma (OS) is a primary bone cancer with a complex tumor microenvironment.
  • Tumor-associated macrophages (TAMs), particularly M1 macrophages, play a crucial role in cancer progression and immune response.
  • Understanding the interaction between OS cells and M1 macrophages is vital for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the interactions between osteosarcoma cells and M1 macrophages.
  • To elucidate the mechanisms by which M1 macrophages influence osteosarcoma growth.
  • To explore novel therapeutic targets for osteosarcoma treatment.

Main Methods:

  • Utilized transwell co-culture and indirect conditioned medium systems.
  • Established orthotopic osteosarcoma bearing models in vivo.
  • Analyzed the roles of secreted factors like HSPA1L and LGALS3BP and associated signaling pathways (IRAK1/4, Akt).

Main Results:

  • Co-culture of M1 macrophages with OS cells inhibited tumor growth by inducing apoptosis.
  • M1 macrophage-secreted HSPA1L mediated anti-tumor effects via IRAK1 and IRAK4 pathways.
  • OS cell-secreted LGALS3BP induced M1 macrophage Hspa11 secretion via Akt phosphorylation, while LGALS3BP silencing promoted OS progression.

Conclusions:

  • Osteosarcoma modulates macrophage phenotype, influencing OS cell apoptosis through soluble factors.
  • Modulating tumor-associated macrophages presents a promising therapeutic avenue for osteosarcoma.
  • The identified molecular interactions provide potential targets for novel osteosarcoma therapies.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K